CoCensys Inc.: The company’s stock gained 22%...
- Share via
CoCensys Inc.: The company’s stock gained 22% Thursday after the biopharmaceutical company announced that it will introduce four psychiatric drugs on an accelerated schedule. CoCensys closed at $3.75 a share, up 69 cents, in heavy Nasdaq trading.
The Irvine-based company said it has completed recruitment of its sales and marketing force ahead of schedule and will actively start promoting the new line of central nervous system drugs on Aug. 1.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
